Charles River Laboratories International, Inc.

符号: CRL

NYSE

233.47

USD

今天的市场价格

25.2401
市盈率
2.6474
PEG比率
11.99B
MRK市值
0.00%
DIV收益率

Charles River Laboratories International, Inc. (CRL) 财务报表

Q: 什么是 Charles River Laboratories International, Inc. (CRL) 总资产是多少？

Charles River Laboratories International, Inc. (CRL) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Charles River Laboratories International, Inc. (CRL). 的默认数据。公司收入显示 1511.744 M 的平均值，即 0.134 % 增长率。整个期间的平均毛利润为 560.185 M，即 0.134 %. 平均毛利率为 0.375 %. 公司去年的净收入增长率为 -0.024 %，等于 0.093 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Charles River Laboratories International, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.078. 在流动资产领域，CRL 的报告货币为1608.662. 这些资产中的很大一部分，即 276.771 是现金和短期投资。与去年的数据相比，该部分的变化率为0.183%. 公司的长期投资虽然不是其重点，但以报告货币计算的243.811（如果有的话）为243.811。这表明与上一报告期相比，-21.756% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 3066.381. 这一数字表明，-0.010% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 3596.882. 这方面的年同比变化率为 0.209%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为780.375，存货估值为 380.26，商誉估值为 3095.05（如有. 无形资产总额（如果有）按 864.05 估值. 应付账款和短期债务分别为 168.94 和 441.12. 债务总额为3066.38，债务净额为 2789.61. 其他流动负债为 203.21，加上总负债 4536. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
balance-sheet.row.cash-and-short-term-investments	835.98	276.8	233.9	241.2	228.4	238	195.4	163.8	117.6	117.9	160	155.9	109.7	68.9	179.2	182.6	243.6	240.4	182.8	116.5	207.8	195.5	122.5	58.3	33.1	15	24.8
balance-sheet.row.short-term-investments	0	0	1	1.1	1	0.9	0.9	28.5	3.8	20.5	16.2	11.2	6.8	5.4	9.8	56.4	0	15	7.5	1.7	0.2	13.2	0	0	0	0	0
balance-sheet.row.net-receivables	3168.64	780.4	752.4	642.9	617.7	514	472.2	430	364.1	270.1	258	220.6	203	184.8	193	196.9	210.2	213.9	202.7	203.3	201.8	111.5	94.2	98.5	45.9	36.3	33.4
balance-sheet.row.inventory	1221.1	380.3	255.8	199.1	185.7	160.7	127.9	115	95.8	93.7	89	89.4	88.5	93	100.3	102.7	96.9	88	72.4	65.3	61.9	52.4	43.9	39.1	33.9	30.5	30.7
balance-sheet.row.other-current-assets	381.79	83.4	107.6	97.3	72.6	56	48.8	81.3	45	47.3	99.8	85.8	83.6	79.1	80.5	113.4	67.5	3.2	6.3	34.3	38.8	11.5	12.4	14.3	6.8	8.2	2.8
balance-sheet.row.total-current-assets	6006.12	1608.7	1439	1274.1	1201.1	1021.3	897.8	826.6	656.8	559.2	606.9	552.5	485.3	425.8	552.9	595.6	618.1	607.9	501.1	419.3	510.3	370.9	278.1	210.2	119.7	90.1	97.2
balance-sheet.row.property-plant-equipment-net	7763.95	2033.8	1857.4	1584	1302.6	1184.2	932.9	782	755.8	678	676.8	676.2	717	738	752.7	865.7	828.9	748.8	534.7	399.5	357.1	203.5	187.9	155.9	117	85.4	82.7
balance-sheet.row.goodwill	11797.87	3095	2849.9	2711.9	1809.2	1540.6	1247.1	804.9	787.5	438.8	321.1	230.7	208.6	197.6	198.4	508.2	457.6	1120.5	1119.3	1417.7	1422.6	0	96.5	52.1	41.9	0	0
balance-sheet.row.intangible-assets	3638.35	864.1	955.3	1061.2	787.6	689.4	610.9	369.8	394.4	280.8	178.9	84.5	84.9	93.4	121.2	160.3	136.1	148.9	160.2	1616.8	1678.9	135.7	130.7	90.4	41.9	37	0
balance-sheet.row.goodwill-and-intangible-assets	15436.21	3959.1	3805.2	3773.1	2596.8	2230	1858	1174.7	1182	719.6	500	315.2	293.5	291	319.7	668.5	593.7	1269.4	1279.5	1616.8	1678.9	135.7	130.7	90.4	41.9	37	17.7
balance-sheet.row.long-term-investments	1139.73	243.8	311.6	201.4	221.8	123	88.6	71.1	45.3	32.7	27	17.9	8.5	0	0	0	0	0	0	0	0	0	0	3	2.4	0	18.5
balance-sheet.row.tax-assets	154.1	40.3	41.3	40.2	37.7	44.7	23.4	22.7	28.7	40	23.2	35.5	38.6	44.8	45	19	62.9	89.3	107.5	67.9	50.4	61.6	80.9	8.7	-2.4	0	5.8
balance-sheet.row.other-non-current-assets	773.71	309.4	148.3	151.5	130.8	89.6	55.2	52.9	43.1	38.9	51.3	47.2	43.5	58.6	63.1	55.2	56.2	90.2	134.7	34.7	30.1	27.9	23.8	103.2	132	150.6	12.4
balance-sheet.row.total-non-current-assets	25267.71	6586.3	6163.7	5750.2	4289.7	3671.5	2958	2103.3	2055	1509.3	1278.3	1092.1	1101.1	1132.5	1180.5	1608.5	1541.8	2197.7	2056.5	2118.9	2116.5	428.7	423.3	361.2	290.9	273	137
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	31273.83	8195	7602.8	7024.3	5490.8	4692.8	3855.9	2929.9	2711.8	2068.5	1885.2	1644.6	1586.3	1558.3	1733.4	2204.1	2159.9	2805.5	2557.5	2538.2	2626.8	799.6	701.3	571.4	410.6	363.1	234.3
balance-sheet.row.account-payables	565.49	168.9	205.9	198.1	122.5	111.5	66.3	77.8	68.5	36.7	33.8	31.8	31.2	34.3	30.6	31.2	40.5	36.7	28.2	30.4	28.7	19.4	13.1	13.9	10.8	9.3	11.6
balance-sheet.row.short-term-debt	1281.68	441.1	50.2	2.8	50.2	38.5	31.4	31	27.3	17	31.9	21.4	139.4	14.8	30.6	35.4	35.5	25.1	25	36.4	80.9	61	67.2	0.9	0.4	3.5	0.4
balance-sheet.row.tax-payables	166.91	38.8	39.9	26.2	24.9	26.1	24.1	43.3	25.6	12.2	9.4	18.8	18.2	10.6	0	0	0	0	0	0	0	0	7	4	0	0	14.3
balance-sheet.row.long-term-debt-total	12213.11	3066.4	3097.3	2916.5	2085.2	1965.9	1636.6	1114.1	1207.7	846	746	642.4	527.1	703.2	670.3	457.4	540.6	485	547.1	260.2	606	185.7	192.5	155.9	202.5	382.5	1.2
Deferred Revenue Non Current	119.13	30.9	25.8	20.6	19.5	21	34.4	3.9	5.8	7.9	-22.5	-6.9	-4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	796.34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1178.82	203.2	571.2	612.6	459.1	388.3	315.4	237.1	206.1	176.7	152.3	139.7	115.2	111.2	131.7	110.7	138.3	138.7	112.9	128.2	122.1	3.1	6	61.5	53.1	56.9	11.2
balance-sheet.row.total-non-current-liabilities	13769.39	3480.9	3487.7	3399.1	2507.4	2316.1	1959.4	1402.4	1428.4	991.2	884.7	732.9	640.9	812.4	784.9	580.5	659.5	639	693.8	390.1	795.4	210.4	212	170.3	216	403.2	3.3
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	1629.5	419.2	389.7	253	155.6	116.3	26.1	27.9	27.2	31.8	24.1	0.7	0	703.2	0	0	0	0	0	0	0	0	0.1	0.4	0	0	1.1
balance-sheet.row.total-liab	17807.3	4536	4579.3	4432.3	3347.2	3026.3	2517.6	1865.9	1858	1302.9	1180.8	980	983.1	1029.2	1044.6	830.3	960.5	941.6	953.1	701.5	1144.5	324.8	325.4	268.9	280.4	472.9	65.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2.05	0.5	0.5	0.5	0.5	0.5	0.5	0.9	0.9	0.9	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.7	0.7	0.7	0.5	0.5	0.4	0.4	0.1	0
balance-sheet.row.retained-earnings	6776.74	1887.2	1432.9	980.8	625.4	280.3	42.1	288.7	165.3	10.5	-138.8	-265.5	-368.3	-465.6	-575.2	-238.5	-344.3	177.5	23.1	78.9	-63.1	-152.9	-233	-283.2	-318.6	-307.4	156.1
balance-sheet.row.accumulated-other-comprehensive-income-loss	-911.89	-196.4	-262.1	-164.7	-138.9	-178	-172.7	-144.7	-253.8	-135.5	-74.2	5.4	6.6	4.6	33.6	45	3.3	85.6	21.2	-12.2	16.1	7.3	-11.8	-16.7	-16.3	-9.9	-5.7
balance-sheet.row.other-total-stockholders-equity	7396.27	1905.6	1804.9	1718.3	1627.6	1531.8	1447.5	900.3	924.4	857.2	884.4	900.3	961.7	987.6	1228.2	1566.5	1539.2	1596.6	1550.2	1759.6	1518.9	609.8	601.7	588.9	451.4	207	17.8
balance-sheet.row.total-stockholders-equity	13263.17	3596.9	2976.3	2534.8	2114.6	1634.6	1317.3	1045.1	836.8	733.1	672.2	641	600.8	527.4	687.4	1373.8	1199	1860.5	1595.2	1827	1472.5	464.6	357.4	289.5	116.9	-110.1	168.3
balance-sheet.row.total-liabilities-and-stockholders-equity	31273.83	8195	7602.8	7024.3	5490.8	4692.8	3855.9	2929.9	2711.8	2068.5	1885.2	1644.6	1586.3	1558.3	1733.4	2204.1	2159.9	2805.5	2557.5	2538.2	2626.8	799.6	701.3	571.4	410.6	363.1	234.3
balance-sheet.row.minority-interest	203.35	62.1	47.2	57.2	29.1	31.9	21	18.9	17	32.5	32.1	23.7	2.4	1.8	1.3	-1.4	0.4	3.5	9.2	9.7	9.8	10.2	18.6	13	13.3	0.3	0.3
balance-sheet.row.total-equity	13466.53	3659	3023.5	2592	2143.7	1666.5	1338.3	1064	853.8	765.6	704.3	664.7	603.2	529.1	688.7	1372.4	1199.4	1864	1604.4	1836.7	1482.3	474.8	375.9	302.5	130.3	-109.8	168.6
balance-sheet.row.total-liabilities-and-total-equity	31273.83	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	1139.73	243.8	311.6	202.4	222.8	123.9	89.5	99.6	49.1	53.2	43.2	29.1	15.3	5.4	9.8	56.4	0	15	7.5	1.7	0.2	13.2	0	3	2.4	0	18.5
balance-sheet.row.total-debt	12213.11	3066.4	3097.3	2919.3	2135.4	2004.5	1668	1145.1	1235	863	777.9	663.8	666.5	717.9	700.9	492.8	576.1	510	572.1	296.7	686.8	185.7	192.5	156.8	202.9	386	1.6
balance-sheet.row.net-debt	11377.13	2789.6	2863.4	2678.1	1907	1766.4	1472.6	981.3	1117.4	745.1	617.8	507.9	556.8	649	521.7	310.3	332.5	284.6	396.7	181.8	479.3	3.4	70	98.5	169.8	371	-23.2

现金流量表

在 Charles River Laboratories International, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.239 的转变。该公司最近通过发行 25.6 扩大了股本，与上一年相比出现了0.786 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-563155000.000. 与上一年相比， -0.074 发生了变化. 在同一时期，公司记录了 314.12, -2.29 和 -851.68，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-25.6 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 790.31，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	480.37	480.4	492.6	398.8	365.3	254.1	227.2	125.6	156.1	152	129.9	105.4	102.1	115.5	-334.1	109.4	-522.3	154.4	-55.8	142	89.8	80.2	50.1	35.4	17.9	17.1	23.4
cash-flows.row.depreciation-and-amortization	314.12	314.1	303.9	265.5	234.9	198.1	161.8	131.2	126.7	94.9	96.4	96.6	81.3	85.2	93.6	93.6	91.2	88.9	85.1	104.6	48.2	31.1	25.7	28.6	18.9	15.6	10.9
cash-flows.row.deferred-income-tax	-50.9	-50.9	-35.9	-24	-0.1	-21.9	-9.7	28.3	1.9	2.7	7.1	-0.8	1.3	-8.7	-42.3	15.8	12.7	-9.8	4	-37.4	9.1	8.9	11.3	17.2	-0.9	8.6	-3.1
cash-flows.row.stock-based-compensation	72.05	72	73.6	71.5	56.3	57.3	47.3	44	43.6	40.1	31	24.5	21.9	21.7	25.5	23.8	24.3	21.1	21.1	17	3.8	0	1	4.5	8.2	0	0
cash-flows.row.change-in-working-capital	-102.38	-102.4	-152.6	42.9	-26.3	6.2	14.8	5.9	-30	9.6	-3.8	-25.4	-26	-27	7.6	-43.4	-32.2	19.2	-58.6	-10.5	12.2	-4.9	16.7	-20.9	-9.3	-2.9	7.4
cash-flows.row.account-receivables	-33.43	-33.4	-150.6	-26.6	-85.6	-8.3	-21.2	-48.3	-52.8	-17	-28.1	-19.5	-16.3	7.7	-5.6	21.8	-8.5	-19	-19	-9.5	-7.3	0	11.7	-27.5	0	0	0
cash-flows.row.inventory	-62.3	-62.3	-78.5	-25.2	-18.4	-21.4	-13.3	-17.8	-4	3.4	-3	-1.6	0.8	3.8	2	-4.4	-9.7	-13	-6.5	-5.8	-6.4	-5.7	-1.6	-3.8	-2.3	0.1	-1.3
cash-flows.row.account-payables	-20.43	-20.4	-2.7	44.9	0.7	29.8	-12.7	0	22.1	1.2	4.6	-7.1	-3.3	2.2	0.1	-11.5	8.2	-2.6	-2.6	2.5	-2.3	0	-3.8	0.3	0	0	0
cash-flows.row.other-working-capital	13.78	13.8	79.2	49.8	77	6.1	62.1	72	4.7	22	22.7	2.8	-7.3	-40.7	11.1	-49.3	-22.2	53.7	-30.6	2.2	28.1	0.9	10.3	10	-7	-3.1	8.6
cash-flows.row.other-non-cash-items	-29.36	-29.4	-62	6	-83.6	-12.8	-0.3	-18.7	0	-13	-9.6	6.7	27.4	18.5	418.7	25.9	706.2	10.4	168.5	21	21.8	8.5	28.9	6.6	-1	-0.9	-1.2
cash-flows.row.net-cash-provided-by-operating-activities	683.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-318.53	-318.5	-324.7	-228.8	-166.6	-140.5	-140.1	-82.4	-55.3	-63.3	-56.9	-39.2	-47.5	-49.1	-42.9	-80	-197.1	-227	-181.7	-95.5	-45.3	-32.7	-37.5	-36.7	-15.6	-13	-11.9
cash-flows.row.acquisitions-net	-203.71	-194.8	-120.1	-1170.4	-418.6	-515.7	-824.9	47.5	-648.5	-247.7	-234.3	-29.2	-16.9	0	2.8	-83.3	-69.2	-11.6	-30.9	-3.4	-572	-10.8	-42.5	-55.3	-6	-23.1	-11.8
cash-flows.row.purchases-of-investments	-54.22	-54.2	-158.3	-45.6	-26.7	-22.3	-25.1	-46.2	-40.2	-34.2	-26.6	-17.6	-18.5	-24.6	-27.6	-102.3	-6.4	-299.4	-207.9	-15.6	-16.7	-21.8	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	6.67	6.7	4.5	6.5	11.4	0.9	35.8	9.1	54	27.1	21	11.6	25.2	31.6	72.5	52.8	45.4	334.5	123	0.4	32.6	1.1	0	0	0	0	0
cash-flows.row.other-investing-activites	6.63	-2.3	-9.3	0.3	-1.1	-3.9	-0.8	-0.5	3.7	-2.2	-1.1	0.3	2.8	5.4	0.9	4	0.1	2.7	189.5	0.1	1.4	0.9	1.2	0	7	1.8	0.7
cash-flows.row.net-cash-used-for-investing-activites	-563.15	-563.2	-607.9	-1437.9	-601.5	-681.5	-955	-72.6	-686.4	-320.3	-298	-74	-55	-36.6	5.8	-208.8	-227.2	-200.8	-108	-114	-600	-63.4	-78.9	-91.9	-14.6	-34.2	-23
cash-flows.row.debt-repayment	-851.68	-851.7	-2932.6	-6242.9	-2200.4	-3124.6	-2201	-372.4	-656.6	-417.3	-194.5	-523.3	-140.3	-253	-381.5	-54.1	-36.5	-62.6	-271.2	-203.8	0	0	0	0	0	0	-1.3
cash-flows.row.common-stock-issued	25.6	25.6	25.1	45.7	46.6	34.5	0	0	0	0	0	0	0	0	0	0	0	54	88.3	27.1	26.6	4	5.3	116.7	236	103	0
cash-flows.row.common-stock-repurchased	-24.16	-24.2	-38.7	-40.7	-24	-18.1	-13.8	-106.9	-12.3	-117.5	-122	-165.9	-64.2	-283.8	-356.5	-45.9	-115.1	-41.6	-250	-18	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	-25.6	0	-45.7	-46.6	-34.5	0	0	0	0	0	0	0	0	0	0	0	-1.9	-1.9	-1.4	-2.1	-1.9	-1.5	-0.7	0	0	0
cash-flows.row.other-financing-activites	778.52	790.3	2903.8	6956.2	2271.6	3374.6	2772.9	270.9	1059.6	539.4	378	605	93.4	265	570.2	19.1	134.3	5.8	440.1	-1.5	412.5	-10.9	1.4	-68.7	-235.2	-114.5	-6.7
cash-flows.row.net-cash-used-provided-by-financing-activities	-85.52	-85.5	-42.4	672.6	47.2	231.9	558.1	-208.5	390.7	4.5	61.4	-84.2	-111.1	-271.8	-167.9	-81	-17.3	-46.4	5.4	-197.6	436.9	-8.8	5.2	47.2	0.8	-11.5	-8
cash-flows.row.effect-of-forex-changes-on-cash	8.04	8	25.6	17.7	0.8	11.4	-9.5	11.2	-3	-12.7	-10.4	-2.6	-1	-7.1	-10.3	3.7	-17.3	13	-1.2	-17.9	3.4	8.2	4.3	-1.5	-1.9	-1.7	0.6
cash-flows.row.net-change-in-cash	43.27	43.3	-5.1	13.2	-6.9	42.7	31	46.4	-0.3	-42.1	4.1	46.2	40.8	-110.3	-3.4	-61	18.1	50.1	60.6	-92.7	25.2	59.8	64.2	25.1	18.1	-9.8	6.9
cash-flows.row.cash-at-end-of-period	867.76	284.5	241.2	246.3	233.1	240	197.3	166.3	117.6	117.9	160	155.9	109.7	68.9	179.2	182.6	243.6	225.4	175.4	114.8	207.6	182.3	122.5	58.3	33.1	15	24.8
cash-flows.row.cash-at-beginning-of-period	824.5	241.2	246.3	233.1	240	197.3	166.3	119.9	117.9	160	155.9	109.7	68.9	179.2	182.6	243.6	225.4	175.4	114.8	207.6	182.3	122.5	58.3	33.1	15	24.8	17.9
cash-flows.row.operating-cash-flow	683.9	683.9	619.6	760.8	546.6	480.9	441.1	316.3	298.3	286.4	251.1	207.1	207.9	205.3	169	225	279.9	284.2	164.4	236.7	184.8	123.8	133.7	71.3	33.8	37.6	37.4
cash-flows.row.capital-expenditure	-318.53	-318.5	-324.7	-228.8	-166.6	-140.5	-140.1	-82.4	-55.3	-63.3	-56.9	-39.2	-47.5	-49.1	-42.9	-80	-197.1	-227	-181.7	-95.5	-45.3	-32.7	-37.5	-36.7	-15.6	-13	-11.9
cash-flows.row.free-cash-flow	365.37	365.4	294.9	532	380	340.4	301.1	233.8	243	223.1	194.1	168	160.4	156.1	126.2	145	82.9	57.2	-17.4	141.2	139.5	91.1	96.1	34.6	18.2	24.6	25.5

利润表行

Charles River Laboratories International, Inc. 的收入与上期相比变化了 0.039%。据报告, CRL 的毛利润为 1502.56。该公司的营业费用为 885.29，与上年相比变化了 9.070%. 折旧和摊销费用为 314.12，与上一会计期间相比变化了 -0.063%. 营业费用报告为 885.29，显示9.070% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.052%. 营业收入为 617.26，与上年相比变化了-0.052%. 净利润的变化率为 -0.024%。去年的净收入为474.62.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
income-statement-row.row.total-revenue	4129.41	4129.4	3976.1	3540.2	2923.9	2621.2	2266.1	1857.6	1681.4	1363.3	1297.7	1165.5	1129.5	1142.6	1133.4	1202.6	1343.5	1230.6	1058.4	1122.2	766.9	613.7	554.6	465.6	306.6	219.3	193.3
income-statement-row.row.cost-of-revenue	2626.85	2626.9	2513.4	2205.5	1850.4	1662.9	1426	1155.3	1034.8	832.2	825	770.6	737.4	740.4	748.7	773.2	832.8	752.4	651.8	693.5	468.4	380.1	345.6	298.4	171.4	120.9	122.5
income-statement-row.row.gross-profit	1502.56	1502.6	1462.7	1334.6	1073.5	958.3	840.1	702.3	646.7	531.1	472.7	394.9	392.1	402.2	384.8	429.4	510.7	478.2	406.6	428.7	298.6	233.7	209	167.3	135.1	98.4	70.8
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	133.73	95.5	146.6	124.9	111.9	89.5	13.3	38.5	11.9	3	10.7	7.2	-3.3	21.8	24.4	28.4	30.3	33.5	37.6	58.2	16.8	4.9	3.4	8.7	18.9	15.6	1.3
income-statement-row.row.operating-expenses	885.29	885.3	811.7	744.8	640.8	607.2	508.7	414.8	409.2	324.6	295	243.5	226.3	227.9	286.9	262.4	260.5	251	218.4	247.7	138.2	95.1	86.7	77	70.1	55.4	35.4
income-statement-row.row.cost-and-expenses	3512.15	3512.1	3325.1	2950.3	2491.2	2270.1	1934.7	1570.1	1444	1156.9	1120	1014.1	963.8	968.3	1035.5	1035.6	1093.3	1003.4	870.2	941.2	606.6	475.2	432.4	375.3	241.5	176.3	158
income-statement-row.row.interest-income	5.2	5.2	0.8	0.7	0.8	1.5	0.8	0.7	1.3	1	1.2	0.7	0.6	1.4	1.2	1.8	8.7	9.7	6.8	3.9	3.3	0	2.1	1.5	0	0	0
income-statement-row.row.interest-expense	136.71	136.7	59.3	73.9	86.4	60.9	63.8	29.8	27.7	15.1	11.9	21	33.3	41.2	34.1	21.7	14	14.8	193.2	22.6	8.7	6.6	27.3	27.3	67.4	8.3	-2.1
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	61.96	95.5	-28	-109.2	14.4	-47.1	13.3	38.5	11.9	3	10.7	7.2	-3.3	-0.4	-397.9	2.1	-705.9	-1.4	1	-0.2	0.7	0.8	1.5	1	1.1	2	-0.1
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	133.73	95.5	146.6	124.9	111.9	89.5	13.3	38.5	11.9	3	10.7	7.2	-3.3	21.8	24.4	28.4	30.3	33.5	37.6	58.2	16.8	4.9	3.4	8.7	18.9	15.6	1.3
income-statement-row.row.total-operating-expenses	61.96	95.5	-28	-109.2	14.4	-47.1	13.3	38.5	11.9	3	10.7	7.2	-3.3	-0.4	-397.9	2.1	-705.9	-1.4	1	-0.2	0.7	0.8	1.5	1	1.1	2	-0.1
income-statement-row.row.interest-expense	136.71	136.7	59.3	73.9	86.4	60.9	63.8	29.8	27.7	15.1	11.9	21	33.3	41.2	34.1	21.7	14	14.8	193.2	22.6	8.7	6.6	27.3	27.3	67.4	8.3	-2.1
income-statement-row.row.depreciation-and-amortization	311.65	314.1	335.2	230.3	335.7	211.9	64.8	41.4	41.7	24.2	26	17.8	18.1	21.8	24.4	28.4	30.3	88.9	85.1	104.6	48.2	31.1	25.7	28.6	18.9	15.6	10.9
income-statement-row.row.ebitda-caps	1032.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	617.26	617.3	651	589.9	432.7	351.2	331.4	287.5	237.4	206.4	177.7	151.4	165.8	174.3	-298.5	166.9	-449.8	227.2	188.2	181	160.3	138.6	122.3	90.3	65.1	43	35.3
income-statement-row.row.income-before-tax	581.28	581.3	623	480.7	447.1	304.1	281.7	297	222.9	195.4	177.6	138.3	129.7	132.7	-334.1	149.1	-461	217.4	176.6	160.4	152.5	132.6	114.4	69.5	25.7	32.7	35.8
income-statement-row.row.income-tax-expense	100.91	100.9	130.4	81.9	81.8	50	54.5	171.4	66.8	43.4	47.7	32.9	27.6	17.1	0	39.7	61.9	59.4	49.7	16.6	61.2	51.1	43.6	27.1	7.8	15.6	14.1
income-statement-row.row.net-income	474.62	474.6	486.2	391	364.3	252	226.4	123.4	154.8	149.3	126.7	102.8	97.3	109.6	-336.7	114.4	-521.8	154.4	-55.8	142	89.8	80.2	50.1	35.4	-11.2	17.1	23.4